Cargando…
Introducing iron isomaltoside 1000 (Monofer®)—development rationale and clinical experience
Patients with chronic kidney disease (CKD) often suffer from iron deficiency anaemia necessitating treatment with intravenous (IV) iron. Several studies demonstrate that oral iron is insufficient in these patients and that IV supplementation is a more effective treatment. Until now, use of available...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813791/ https://www.ncbi.nlm.nih.gov/pubmed/27045417 http://dx.doi.org/10.1093/ndtplus/sfr042 |